KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Current Deferred Revenue (2018 - 2025)

Fulgent Genetics' Current Deferred Revenue history spans 7 years, with the latest figure at $3.6 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 62.71% year-over-year to $3.6 million; the TTM value through Dec 2025 reached $3.6 million, up 62.71%, while the annual FY2025 figure was $3.6 million, 62.71% up from the prior year.
  • Current Deferred Revenue for Q4 2025 was $3.6 million at Fulgent Genetics, up from $2.3 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $14.6 million in Q4 2021 and bottomed at $2.2 million in Q4 2024.
  • The 5-year median for Current Deferred Revenue is $2.8 million (2023), against an average of $5.3 million.
  • The largest annual shift saw Current Deferred Revenue skyrocketed 3044.14% in 2021 before it crashed 80.62% in 2023.
  • A 5-year view of Current Deferred Revenue shows it stood at $14.6 million in 2021, then crashed by 78.04% to $3.2 million in 2022, then decreased by 10.16% to $2.9 million in 2023, then dropped by 22.27% to $2.2 million in 2024, then skyrocketed by 62.71% to $3.6 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Current Deferred Revenue are $3.6 million (Q4 2025), $2.3 million (Q3 2025), and $2.7 million (Q2 2025).